Sehnde, Germany

George Shlieout

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Sehnde, DE (2014 - 2022)
  • Hannover, DE (2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovator Behind Advanced Enzyme Compositions - George Shlieout

Introduction

George Shlieout, an accomplished inventor based in Sehnde, Germany, has made significant contributions to the field of biochemistry. With a portfolio of four patents, he has focused on innovative solutions that aim to enhance the safety and efficacy of enzyme preparations, particularly in pharmaceutical applications.

Latest Patents

Shlieout's recent inventions include groundbreaking advancements in enzyme compositions designed to minimize viral and microbial contamination. This particular invention details an enzyme preparation derived from e-beam irradiated animal tissue, specifically porcine pancreas. It encompasses methods for creating such enzyme preparations, along with pharmaceutical compositions incorporating them, as well as the methodologies for their practical use.

Another noteworthy patent pertains to the manufacturing and application of pancreatin micropellet cores. This process is notable for producing pancreatin micropellets that are largely free of synthetic oils. A key benefit of his invention is the designed enteric coating, which is crafted to deliver pancreatin effectively to the upper portion of the intestine in mammals, ensuring optimal release.

Career Highlights

Throughout his career, George Shlieout has been associated with prominent companies in the healthcare sector, including Abbott Products GmbH and AbbVie Inc. His work in these organizations has allowed him to refine his expertise and contribute to significant advancements in enzyme technology.

Collaborations

In his journey of innovation, Shlieout has collaborated with notable colleagues such as Frithjof Sczesny and Claus-Juergen Koelln. These professional relationships have fostered a collaborative environment that enhances the development of innovative solutions in enzyme applications.

Conclusion

George Shlieout's dedication to advancing enzyme technology positions him as a key player in the field of biochemistry. His innovative patents reflect a commitment to improving pharmaceutical compositions, demonstrating the potential for safer and more effective treatments. As he continues his work, Shlieout is likely to influence the landscape of enzyme applications for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…